Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Response to fluvoxamine augmentation for obsessive and compulsive symptoms in schizophrenia.

Dwivedi S, Pavuluri M, Heidenreich J, Wright T.

J Child Adolesc Psychopharmacol. 2002 Spring;12(1):69-70. No abstract available.

PMID:
12014598
3.

Obsessive-compulsive disorder with non-24-hour sleep-wake syndrome.

Morinobu S, Yamashita H, Yamawaki S, Tanaka K, Ohkawa M.

J Clin Psychiatry. 2002 Sep;63(9):838-40. No abstract available.

PMID:
12363127
4.

The first Japanese pediatric case of obsessive-compulsive disorder who responded to a selective serotonin re-uptake inhibitor.

Furusho J, Kubagawa T, Saitoh N, Matsuzaki K, Yamakawa H, Iikura Y.

Pediatr Int. 2000 Aug;42(4):451-2. No abstract available.

PMID:
10986886
5.

Tiagabine augmentation to fluvoxamine-risperidone combination in the treatment of obsessive-compulsive disorder.

Oulis P, Masdrakis VG, Karapoulios E, Karakatsanis NA, Kouzoupis AV, Konstantakopoulos G, Soldatos CR.

World J Biol Psychiatry. 2009;10(4 Pt 3):953-5. doi: 10.1080/15622970701739526.

PMID:
19224410
6.
7.

Risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.

McDougle CJ, Fleischmann RL, Epperson CN, Wasylink S, Leckman JF, Price LH.

J Clin Psychiatry. 1995 Nov;56(11):526-8.

PMID:
7592506
8.

Euprolactinemic gynecomastia and galactorrhea with risperidone-fluvoxamine combination.

Pratheesh PJ, Praharaj SK, Srivastava A.

Psychopharmacol Bull. 2011;44(1):70-3.

PMID:
22506441
9.

A case of social phobia with obsessive-compulsive symptoms improved by paroxetine in combination with risperidone.

Yamauchi K, Ohta K, Taniguchi T, Ohmori T.

Gen Hosp Psychiatry. 2004 May-Jun;26(3):242-3. No abstract available.

PMID:
15121355
10.

Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

Erzegovesi S, Guglielmo E, Siliprandi F, Bellodi L.

Eur Neuropsychopharmacol. 2005 Jan;15(1):69-74.

PMID:
15572275
11.

Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression.

Apter A, Ratzoni G, King RA, Weizman A, Iancu I, Binder M, Riddle MA.

J Am Acad Child Adolesc Psychiatry. 1994 Mar-Apr;33(3):342-8.

PMID:
8169178
12.

Serotonin reuptake inhibitor treatment of obsessive-compulsive symptoms in clozapine-medicated schizophrenia.

Andrade C.

J Clin Psychiatry. 2012 Nov;73(11):e1362-4. doi: 10.4088/JCP.12f08200. No abstract available.

13.

Fluvoxamine in the treatment of obsessive-compulsive disorder and related conditions.

Goodman WK, Ward H, Kablinger A, Murphy T.

J Clin Psychiatry. 1997;58 Suppl 5:32-49. Review.

14.

The use of sumatriptan in the treatment of obsessive-compulsive disorder in an adolescent.

Pathak S, Cottingham EM, McConville BJ.

J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S93-4. No abstract available.

PMID:
12880505
15.

Comparable dopamine 2 receptor occupancy.

de Haan L, van Amelsvoort T.

Am J Psychiatry. 2002 Dec;159(12):2118; author reply 2118-9. No abstract available.

PMID:
12450982
16.

A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder.

McDougle CJ, Epperson CN, Pelton GH, Wasylink S, Price LH.

Arch Gen Psychiatry. 2000 Aug;57(8):794-801.

PMID:
10920469
17.

Risperidone augmentation of serotonin reuptake inhibitor treatment of pediatric obsessive compulsive disorder.

Fitzgerald KD, Stewart CM, Tawile V, Rosenberg DR.

J Child Adolesc Psychopharmacol. 1999;9(2):115-23.

PMID:
10461822
18.

Fluvoxamine augmentation in risperidone-resistant schizophrenia: an open trial.

Takahashi H, Sugita T, Higuchi H, Shimizu T.

Hum Psychopharmacol. 2002 Mar;17(2):95-8.

PMID:
12404698
19.

Response to risperidone addition in fluvoxamine-refractory obsessive-compulsive disorder: three cases.

Berigan TR, Harazin JS.

J Clin Psychiatry. 1996 Dec;57(12):594-5. No abstract available.

PMID:
9010126
20.

Risperidone, serotonergic mechanisms, and obsessive-compulsive symptoms in schizophrenia.

Kopala L, Honer WG.

Am J Psychiatry. 1994 Nov;151(11):1714-5. No abstract available.

PMID:
7524373
Items per page

Supplemental Content

Write to the Help Desk